Table 1.
Patient ID | Sex | Genotype |
Biochemical phenotype | Age at diet onset (days) | Age at the study (yrs/mo) | IDC (μM) birth to 10 years and 11 months | IDC (μM) 11 years to the study | Time-gap since diet continuation (yrs/mo) | |
---|---|---|---|---|---|---|---|---|---|
Allele 1 | Allele 2 | ||||||||
01 | F | p.Arg261Gln | c.1066-11G > A | CPKU | 14 | 10/1 | 434 | – | On dieta |
02 | F | p.Arg408Trp | p.Arg408Trp | CPKU | 10 | 10/8 | 486.5 | – | On diet |
03 | M | p.Tyr414Cys | c.1066-11G > A | MPKU | 37 | 10/9 | 353 | – | On dieta |
04 | M | p.Leu48Ser | p.Leu369Leu | MPKU | 22 | 10/11 | 356.5 | – | On dieta |
05 | M | p.Asp59Val | p.Arg261Gln | MPKU | 31 | 10/11 | 313 | – | On dieta |
06 | F | p.Arg261Gln | p.Arg176a | MPKU | 30 | 12/11 | 375 | 865 | On diet |
07 | M | p.Tyr414Cys | p.Arg408Gln | HPA | 21 | 13/10 | 346 | 393 | 3/0 |
08 | F | p.Leu48Ser | p.Leu48Ser | MPKU | 44 | 14/9 | 298 | 422 | 3/3 |
09 | M | c.1066-11G > A | p.Arg176a | CPKU | 15 | 16/3 | 358.5 | 743.5 | On diet |
10 | M | c.1066-11G > A | p.Gly352Cys | MPKU | 30 | 16/11 | 370 | 571a | 3/0 |
11 | M | p.Asp338Tyr | p.Pro281Leu | MPKU | 32 | 17/1 | 322 | 545 | 3/6a |
12 | F | p.Leu194Pro | p.Arg261a | CPKU | 16 | 17/3 | 388 | 1050.5 | 4/3 |
13 | M | c.1066-11G > A | p.Tyr414Cys | MPKU | 14 | 17/3 | 542 | 606 | On dieta |
14 | M | p.Arg261Gln | p.Arg408Gln | MPKU | 12 | 17/11 | 231 | 478 | On diet |
15 | M | p.Arg408Trp | p.Arg408Trp | CPKU | 25 | 17/11 | 545 | 754 | On diet |
16 | F | p.Arg261Gln | p.Arg158Gln | MPKU | 20 | 18/2 | 235 | 699 | On diet |
17 | M | p.Pro281Leu | p.Arg158Gln | CPKU | 30 | 20/0 | 600 | 834.75 | 0/5 |
Mean | 23.7 | 385.5 | 647.9 | ||||||
SD | 9.69 | 105 | 198 | ||||||
Range | 10–44 | 231–600 | 393–1050 |
CE, clinical examination; IDC, index of dietary control, median value of Phe for the considered period; yrs/mo, years/months; CPKU, classical PKU (blood Phe at diagnosis or under free diet persistently >1200 μM); MPKU, mild PKU (blood Phe at diagnosis or under free diet persistently >600 <1200 μM); HPA, persistent hyperphenylalaninemia (blood Phe at diagnosis or under free diet persistently >360 <600 μM).
a Under sapropterin treatment